Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

surf1944

02/03/09 2:49 PM

Post #1

3-Feb-09 Ladenburg Thalmann Downgraded from Buy to Neutral....The risk now is to the downside, upside is limited to a few pennies, downside a couple dollars(may be even a short sell)

PharmaNet Development Group, Inc. (PDGI)

Followers	0	Posters	1
Posts (Today)	0	Posts (Total)	1
Created	01/09/09	Type	Free
Moderators

PharmaNet Development Group, Inc., a drug development services company, provides clinical drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies worldwide. The company�s Early Stage Clinical Development segment engages in designing studies, recruiting and screening study participants, conducting early stage clinical trials, and collecting and reporting clinical data collected during the course of the clinical trials. This segment also offers statistical analysis, medical report writing services, and assistance with regulatory submissions; and bioanalytical support for preclinical studies, drug discovery, early clinical trial studies, bioequivalence studies, bioavailability studies, and drug metabolism studies. Its Late Stage Clinical Development segment offers late stage clinical development services for studies, including clinical operations, data management and biostatistics, regulatory, medical and scientific affairs, and consulting. This segment provides various services in support of clinical trials comprising strategic planning, protocol/case report form design, site selection, monitoring and project management, software systems development and support, quality control/assurance, safety, and pharmacovigilance and post-FDA approval development services. The company also offers biostatistical and programming services to facilitate data processing, analysis, and reporting of results. It provides clinical development services in various therapeutic areas, such as oncology, neurosciences, cardiovascular, and infectious diseases. The company, formerly known as SFBC International, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey.